Hodges Capital Management’s GSK GSK Stock Holding History

Hodges Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,408	Closed	-$203K	–	225
2020 Q4	$203K	Hold	4,408	–	–	0.03%	196
2020 Q3	$207K	Hold	4,408	–	–	0.04%	186
2020 Q2	$225K	Buy	4,408 +88	+2%	+$4.51K	0.05%	174
2020 Q1	$205K	Sell	4,320 -800	-16%	-$42.7K	0.05%	160
2019 Q4	$301K	Hold	5,120	–	–	0.04%	172
2019 Q3	$273K	Hold	5,120	–	–	0.03%	181
2019 Q2	$256K	Hold	5,120	–	–	0.03%	191
2019 Q1	$267K	Hold	5,120	–	–	0.03%	203
2018 Q4	$245K	Sell	5,120 -2,720	-35%	-$134K	0.03%	201
2018 Q3	$394K	Hold	7,840	–	–	0.03%	201
2018 Q2	$395K	Hold	7,840	–	–	0.03%	199
2018 Q1	$383K	Buy	+7,840	New	+$365K	0.03%	198

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Hodges Capital Management's GSK Position: Q1 2021 in Review

Hodges Capital Management sold out of GSK (GSK) in Q1 2021, closing a stake of 4,408 shares — an estimated $203K sold.

Hodges Capital Management first reported a position in GSK in Q1 2018 and held it in 12 quarters. The position peaked at $395K in Q2 2018. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

Hodges Capital Management reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
Hodges Capital Management sold 4,408 GSK shares in Q1 2021, an estimated $203K.
Hodges Capital Management first reported a position in GSK in Q1 2018 and held it in 12 quarters.
Hodges Capital Management's GSK position peaked at $395K in Q2 2018.
774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Hodges Capital Management's 13F filing for Q1 2021, filed 7 Apr 2021.